Hormonal effects of toremifene in breast cancer patients
- 22 June 1990
- journal article
- clinical trial
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 36 (3), 243-247
- https://doi.org/10.1016/0022-4731(90)90018-n
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A new triphenylethylene compound, Fc-1157aCancer Chemotherapy and Pharmacology, 1986
- A new triphenylethylene compound, Fc-1157aCancer Chemotherapy and Pharmacology, 1986
- Hormonal Changes during a Prolonged Tamoxifen Treatment in Patients with Advanced Breast CancerOncology, 1986
- Endocrine and clinical consequences of combination tamoxifen – aminoglutethimide in postmenopausal breast cancerBritish Journal of Cancer, 1984
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- MECHANISM OF INCREASED PROLACTIN SECRETION BY SULPIRIDEJournal of Endocrinology, 1977
- Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course.BMJ, 1977
- Plasma hormones in patients with advanced breast cancer treated with tamoxifenEuropean Journal of Cancer (1965), 1976
- EFFECT OF THE ANTI-OESTROGEN TAMOXIFEN ON PLASMA LEVELS OF LUTEINIZING HORMONE, FOLLICLE-STIMULATING HORMONE, PROLACTIN, OESTRADIOL AND PROGESTERONE IN NORMAL PRE-MENOPAUSAL WOMENJournal of Endocrinology, 1976
- INHIBITION OF OESTROGEN-STIMULATED PROLACTIN RELEASE BY ANTI-OESTROGENSJournal of Endocrinology, 1975